# DESCRIPTION

## BACKGROUND

- motivate human vaccine research
- limitations of in vivo human study
- introduce humanized mouse models
- limitations of current mouse models
- describe DRAG mice
- limitations of DRAG mice
- introduce DRAGA mice
- describe additional mouse strains
- motivate passive transfer of human hyper-immune sera
- introduce monoclonal antibodies
- limitations of animal-derived mAbs
- describe XENOMOUSE technology
- limitations of XENOMOUSE technology

## DETAILED DESCRIPTION OF THE INVENTION

- define terms and concepts

### Definitions

- define transgene
- define knockout mutation
- define transgenic animal
- define knockout animal
- define humanized mouse
- define inbreeding
- define intercross
- define crossbred
- define backcross
- define MHC
- define HLA
- define human costimulatory molecules
- define Rag
- define IL2Rgc
- define HLA-A2.1 Tg
- define HLA-DR*0401 Tg
- define Beta2-microglobulin KO
- define Abb KO

### Example 1: Generation of DRAG and DRAG80 Mouse Strains

- introduce mouse strains
- describe generation of HLA-DR4 Tg, Abb KO, Rag2 KO mice
- describe generation of HLA-DR4 Tg, hCD80 Tg, Abb KO, Rag2 KO mice
- describe genetic construction of RIP-hCD80
- describe expression of hCD80 in pancreatic beta-cells
- describe generation of DRAG mice
- describe generation of DRAG80 mice
- describe inbreeding of HLA-DR4 and hCD80 Tg into NOD background
- describe introduction of IL2Rγ KO mutation
- describe selection of DRAG and DRAG80 mice

### Example 2: Functionality Testing of DRAG and DRAG80 Transgenic Mouse

- introduce DRAG and DRAG80 transgenic mice
- describe irradiation and injection of human hematopoietic stem cells
- compare human T cell reconstitution in DRAG and control mice
- describe thymic differentiation of T cell precursors
- test function of human T cells in DRAG mice
- stimulate T cells with human CD3/CD28 antibodies
- compare T cell response in DRAG and control mice
- describe development of human regulatory CD4+FOXP3+ T cells
- compare development of Tregs in DRAG and control mice
- describe development of serum levels of human IgM and IgG
- compare human B cell reconstitution in DRAG and control mice
- test function of human B cells in DRAG mice
- describe development of human IgG1, IgG2, IgG3, IgG4 subclasses
- test ability to elicit specific IgG antibodies upon vaccination
- describe immunization with tetanus toxoid vaccine
- compare anti-TT IgG antibody levels in DRAG and control mice

### Prophetic Example 3: Functionality Test for DRAG80

- describe expression of human CD80 in transfected cells

### Example 4: Generation of DRAGA Mouse Model

- describe generation of DRAGA mouse model
- generate F1 hybrids with genotype HLA-DR4+/−, HLA-A2.1+/−.hCD80+/−.B
- generate DRAGA mouse strain
- confirm genotype of DRAGA mouse strain
- describe four new humanized mouse strains obtained

### Example 5: Functionality Testing of Transgenic Mouse DRAGA

- describe expression of HLA-DR4 and HLA-A2 molecules in DRAGA mice
- confirm functionality of DRAGA mice
- describe use of DRAGA mice in evaluating human vaccines

### Prophetic Example 6: Testing DRAGA Mice and Derivates' Ability to Elicit HLA-A2.1-Specific Cytotoxic Cells Upon Immunization

- test ability to elicit HLA-A2.1-specific cytotoxic cells upon immunization

### Prophetic Example 7: Generate Therapeutic Human Monoclonal Antibodies to Infectious Agent Using DRAG Mice as Source of Human B Cells

- immunize DRAG mice with irradiated P. falciparum sporozoites
- generate human mAbs against P. falciparum sporozoites/liver stage parasites

